Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial
Titel:
Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial
Auteur:
Basch, Ethan Autio, Karen Ryan, Charles J Mulders, Peter Shore, Neal Kheoh, Thian Fizazi, Karim Logothetis, Christopher J Rathkopf, Dana Smith, Matthew R Mainwaring, Paul N Hao, Yanni Griffin, Thomas Li, Susan Meyers, Michael L Molina, Arturo Cleeland, Charles